Combination therapy with alisertib enhances the anti-tumor immunity induced by a liver cancer vaccine

Summary: Alisertib is a potent aurora A kinase inhibitor in clinical trials for cancer treatment, but its efficacy on cancer vaccines remains unclear. Here, we developed a DNA vaccine targeting glypican-3 (pGPC3) and evaluated its efficacy with alisertib in hepatocellular carcinoma (HCC) models. The...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Fang Xue, Jing Liu, Jinyan Wu, Xueer Li, Ningning Zhu, Shuting Tang, Mengli Zhang, Huan Duan, Rui Wang, Jing Zhang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2025-04-01
סדרה:	iScience
נושאים:	Natural sciences Biological sciences Immunology Systems biology Cancer systems biology
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2589004225003803
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!